Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV | MicrobiomeTrials← Back to trialsNCT04902443
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2021-12-10Est. Completion: 2026-12-01
Enrollment target: 58 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative SyndromeHodgkin LymphomaLymphoma, Non-HodgkinMyelomaChronic Lymphocytic Leukemia
The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic h…
Amiens, FranceEst. completion May 2030
Clonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined Significance
Background:
Clonal Hematopoiesis of Indeterminate Potential (CHIP) is a change in a person s DNA that can increase a pe…
Bethesda, United StatesEst. completion Sep 15, 2033
Recurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaRichter Syndrome
This phase II trial tests how well adding lisocabtagene maraleucel (liso-cel) to nivolumab and ibrutinib works in treati…
Duarte, United StatesEst. completion Sep 10, 2026